OAM
BPTH

Oxford Asset Management’s Bio-Path Holdings Inc BPTH Stock Holding History

Oxford Asset Management’s Portfolio BPTH Stock Details BPTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-6
Closed -$9K – 1750
2017
Q2 		$9K Buy
+6
New +$12.6K ﹤0.01% 1440

Other funds holding BPTH

UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RCA
Rowland Carmichael Advisors Scottsdale, Arizona $316M AUM 18.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Oxford Asset Management's BPTH Position: Q3 2017 in Review

Oxford Asset Management sold out of Bio-Path Holdings Inc (BPTH) in Q3 2017, closing a stake of 6 shares — an estimated $9K sold.

Oxford Asset Management first reported a position in BPTH in Q2 2017 and held it in 1 quarter. The position peaked at $9K in Q2 2017. 26 funds tracked by Wall St. Rank hold BPTH as of Q3 2017.

  • Oxford Asset Management reported no remaining Bio-Path Holdings Inc position as of Q3 2017 after selling out during the quarter.
  • Oxford Asset Management sold 6 Bio-Path Holdings Inc shares in Q3 2017, an estimated $9K.
  • Oxford Asset Management first reported a position in Bio-Path Holdings Inc in Q2 2017 and held it in 1 quarter.
  • Oxford Asset Management's Bio-Path Holdings Inc position peaked at $9K in Q2 2017.
  • 26 funds tracked by Wall St. Rank held Bio-Path Holdings Inc as of Q3 2017.

Based on Oxford Asset Management's 13F filing for Q3 2017, filed 13 Nov 2017.